Skip to main content
000250KOSDAQ

SAM Chun Dang Pharm

243,500
+2,500 (+1.04%)

Price chart

  • MA5
  • MA20
  • MA60
Market capitalizationKRW 1T

Each day's close multiplied by the listed share count of this share class alone, sampled weekly. It is the figure for this issue only, not a combined total across common and preferred shares.

Overview

Summary

SAM Chun Dang Pharm was established on December 29, 1943. The company is headquartered in Hwaseong, Gyeonggi Province, and is listed on the KOSDAQ market.

The company produces and distributes prescription pharmaceuticals including antibiotics and treatments for circulatory and digestive diseases. Its business segments include ophthalmic products and pharmaceutical wholesale through subsidiaries such as Optus Pharm and SCD Japan.

Business overview as filed

(1) 사업부문 정보[지배회사의 개요]당사는 1943년 의약품 제조업 및 판매업을 사업목적으로 하여 설립되었으며, 1985년 경기도 화성시 향남제약단지내에 KGMP공장을 준공하여 항생제, 순환기질환치료제, 소화기질환치료제 및 안약류 등 처방위주의 전문의약품을 생산ㆍ판매하고 있습니다. 당사의 당기 연결 매출액은 전기(2024년) 대비 9.9% 증가한 2,318억원이며,연결 영업이익은 85억원, 연결 당기순이익은 116억원입니다.

[종속회사의 개요] 당사의 사업보고서 작성 기준일 현재 연결재무제표 작성 대상에 포함된 종속기업의 현황은 다음과 같습니다. 옵투스제약은 점안제 및 안과용제 등 의약품 제조 및 판매를, SCD US, INC는 미국 등 북미지역에서 기타 금융투자업, 수출품목 인증 및 승인을 목적으로 설립된 회사입니다. SCD BIOTECH, LLC는 수출품목 인증 및 승인을 목적으로 설립됐으며, SCD US, INC가 100%의 지분을 소유하고 있습니다. SCD JAPAN은 일본에서 의약품도매업을 목적으로 설립된 회사입니다. 종속회사 옵투스제약의 당기 개별 매출액은 전기(2024년) 대비 6.4% 증가한 871.6억원이며, 개별 영업이익은 88.7억원, 개별 당기순이익은 113.6억원입니다.

Company overview

(1) 연결대상 종속회사 개황가. 연결대상 종속회사 현황(요약)

나. 연결대상회사의 변동내용

(2) 회사의 법적, 상업적 명칭당사의 명칭은 삼천당제약 주식회사라고 표기합니다.또한 영문으로는 SAM CHUN DANG PHARM. CO., LTD라 표기합니다. 단, 약식으로 표기할 경우에는 삼천당제약(주) 또는 SCD PHARM. CO., LTD라고 표기합니다.

(3) 설립일자 및 존속기간당사는 의약용 약제품 제조 판매를 영위할 목적으로 1943년 12월 29일에 설립되었습니다. 또한 2000년 10월 04일에 한국거래소가 개설하는 코스닥시장에 상장되어 매매가 개시되었습니다. 회사의 존속기간은 본 보고서 제출일 기준 설립일로부터 만 81년이 경과하였습니다.

(4) 본사의 주소, 전화번호 및 홈페이지주소 : 경기도 화성시 만세구 향남읍 제약공단2길 71전화번호 : 031) 350-7300홈페이지 : http://www.scd.co.kr

(5) 중소기업 등 해당 여부

주) 당사는 보고서 작성기준일 현재 중소기업기본법 제2조 및 중소기업기본법 시행령 제3조에 의거 중소기업에 해당되지 않습니다.

(7) 신용평가에 관한 사항

가. 신용등급 변동내역

나. 신용평가사의 신용등급 체계 및 등급 의미

(8) 회사의 주권상장(또는 등록ㆍ지정) 및 특례상장에 관한 사항

Transcribed verbatim from the sentences the filer wrote in the fiscal 2025 business report (received 2026.06.02), tables and figures omitted.

  • The summary is written separately from the filed text and is not the filer's wording, so it may phrase things differently from or omit parts of the original, which is shown alongside for checking.
  • The company introduction reproduces the sentences the filer wrote in its business report, with tables, figures and the sentences that point to other sections of the report omitted, and the accuracy of their content has not been separately verified.

VaR

6.69%
[4.33%, 10.61%] · As of 2026-10-02
VaR by window

The headline's measure for each of the three windows on one scale, the dot being the estimate and the bar its interval. The windows are nested and share their observations, so the three readings are not three independent measurements. The selected window is highlighted.

Daily return distribution

The issue's daily returns over the chosen window counted into equal-width bins. The vertical lines mark the VaR and cVaR above on the loss side. The published VaR sample applies exclusion rules for halts and first sessions that this raw daily series does not, so the bars and the marks can differ slightly at the edges.

Drawdown

Deepest drawdown 89.3% (2026-07-29). How far below its previous peak the issue stood each day over the chosen window, a description of the path already travelled.

If these numbers are unfamiliarThere is a guide that walks through VaR, cVaR and annualized volatility in plain language.Read the guide

Characteristic line

1.15
Beta [0.93, 1.38] · KOSDAQ150 · As of 2026-10-08
Intercept
+0.138%[-0.573%, +0.848%]
R squared
0.33
Observations
252
Trading-time corrected beta
1.26[0.89, 1.63]
252-day rolling beta

A 252-day window rolled one day at a time over the longest daily span of the characteristic line. It shows when the beta against the KOSDAQ150 and the annualized volatility of the issue's excess return rose and fell, and unlike the headline figures above it carries no interval.

252-day rolling annualized volatility

Each point is one period's index excess return and issue excess return, and the line is the regression fitted to those points. The risk-free rate is the certificate of deposit rate.

Financials

20152016201720182019202020212022202320242025TTM
RevenueKRW 100M1,3211,4741,6111,6001,8661,6691,6731,7731,9272,1092,3182,599
Revenue growth%—11.599.32-0.7116.66-10.580.256.018.659.479.90—
Operating incomeKRW 100M20824426515525255-153122962685177
Operating income growth%—17.328.84-41.5462.64-78.09-376.90—-21.80-72.36220.46—
Net incomeKRW 100M17915623014619675-10488-42-51120255
Net income growth%—-12.6547.49-36.6334.31-61.76-238.24—-147.42———
Attributable to ownersKRW 100M1168715188105-10-16658-104-10953178
Attributable to minoritiesKRW 100M626980589185623062586877
Operating margin%15.7216.5316.469.6913.513.31-9.146.894.961.253.656.83
Net margin%13.5310.5914.299.1210.504.49-6.194.98-2.17-2.415.199.80
ROE%——10.295.896.62-0.52-9.513.36-4.71-4.101.915.88
ROA%9.707.619.795.596.762.36-3.012.37-1.03-0.982.144.43
Debt ratio%19.4119.9518.3126.9230.0023.0437.4151.9636.7148.7654.3643.57
Current ratio%455.69445.96553.63370.32359.45703.89312.70413.39282.81259.61226.85221.14
Quick ratio%373.99372.64461.44311.93308.49596.79261.04329.76221.96218.73177.48165.72
Reserve ratio%——1,109.981,196.951,279.141,491.441,400.431,399.871,753.431,665.131,748.821,771.95
Free cash flowKRW 100M87137254135240-54-226-3316747-364—
FCF margin%6.589.2715.758.4312.87-3.25-13.50-1.838.652.25-15.68—
OCF conversion%97.02113.77124.33171.55156.1443.36—150.35——81.41—
Capex to revenue%6.552.792.027.223.535.208.909.323.518.0719.91—
Receivable daysdays—87.587.486.373.681.776.974.368.580.189.3—
Inventory daysdays—98.698.7105.3109.3121.2115.4125.0128.1120.5135.4—
Payable daysdays—82.682.294.8105.6100.792.3102.986.8100.6144.4—
Cash conversion cycledays—103.5103.996.877.3102.299.996.3109.8100.080.3—
EPSKRW570422704409488-45-750265-463-474226758
PERx—27.7321.9592.9172.95——165.28——1,028.76298.13
BPSKRW——6,6206,7197,1428,1977,6467,6319,40011,34411,76712,893
PBRx——2.335.664.9810.025.675.748.2213.0919.7617.53
Dividend per shareKRW5050505050————20050—
Payout ratio%8.7711.857.1012.2210.25—————22.12—

Consolidated basis

Profit flowKRW 100M

Revenue
2,318
Cost of sales
1,224
Gross profit
1,094
SG&A expenses
1,009
Operating income
85
Non-operating income
41
Profit before tax
125
Net income
120
Income tax expense
5

This diagram traces where revenue goes at each step on its way to net income, using the filed amounts as they are. The non-operating result is taken as the difference between profit before tax and operating income and is shown as income or expense by its sign, and whatever a step's items leave unexplained is shown separately as other.

Revenue compositionKRW 100M

Margins%

Cash flow by activityKRW 100M

Balance sheet compositionKRW 100M

Debt ratio%

The left bar splits assets into current and non-current and the right bar splits the financing of those assets into liabilities and equity, so the two bars stand at the same height.

Quarterly resultsKRW 100M

Year-on-year growth%

Each quarterly bar is that quarter's three months and is never mixed with an annual figure. The growth rate is computed only where the same quarter a year earlier is also shown here, and is left blank when the base was a loss.

Cash conversion cycledays

Free cash flow breakdownKRW 100M

Inventory days and receivable days stack upward, payable days hang downward, and the cash conversion cycle they net to is drawn as the line. Each day count uses the average balance with the prior year, so the oldest year is not drawn. A day count whose line was not filed is left out, and the cycle is shown only for years that carry all three.

Free cash flow is cash from operating activities less spending on property, plant and equipment, and all three bars keep the sign as filed.

Owners' net margin%

Asset turnoverx

Financial leveragex

ROE%

ROE is the product of the owners' net margin, asset turnover and financial leverage. All three use period-end balances as denominators, and profit and equity are on the owners' basis, so the product matches the ROE in the table.

Financial statements

Balance sheet

20152016201720182019202020212022202320242025
1,8432,0512,351*2,6122,9023,1713,4393,733*4,0805,1985,612
2993413645546705949361,276*1,0961,7041,976
1,5431,7101,988*2,0582,2322,5772,5032,4562,9853,4943,636

Income statement

20152016201720182019202020212022202320242025
1,3211,4741,611*1,6001,8661,6691,6731,7731,9272,1092,318
208244265*15525255-153122962685
208227266*145193166-19589-45110125
179156230*14619675-10488-42-51120
Basic earnings per shareKRW570422704*409488-45-750265-463-474226
Diluted earnings per shareKRW553413704*409488-45-750426159-474226
160158294*14119579-6494-56-54122

Cash flow statement

20152016201720182019202020212022202320242025
Net incomefrom the income statement17915623014619675-10488-42-51120
Total adjustments to operating cash flowcomputed-52256104110-422744276268-22
173178286*25030632-7713323421898
-138-72-119*-503-193-192-301-539-84-232-424
-1932-33148-2414727713334658228
Cash at beginning of periodKRW 100M3313494866195156035894912214041,056
3494866195156035894912214041,056959
Net change in cash and cash equivalentsKRW 100M18138133-10488-13-98-270183652-96

In the latest fiscal year operating and financing activities brought cash in while investing activities spent it.

A year whose own filing is absent is filled from the restated comparative in the following filing, and is marked as such. Operating indicators outside the statements, such as order backlogs, and audit opinions are not covered here, and per-share figures follow the filed values without retroactive adjustment for share splits.

Transcribed verbatim from the sentences the filer wrote in the fiscal {year} business report (received {date}), with tables, figures and cross-references to other sections omitted.

The newest annual filing shown was received on 2026.06.02.

Audit opinion

Fiscal yearOpinionAuditorFiscal year end
2025적정의견Term 82선진회계법인2025-12-31
2024적정의견Term 81선진회계법인2025-12-31
2023적정의견Term 80진일회계법인2025-12-31
2022적정Term 79진일회계법인2022-12-31
2021적정Term 78진일회계법인2022-12-31
2020적정Term 77선진회계법인2022-12-31
2019적정Term 76선진회계법인2019-12-31
2018적정Term 75선진회계법인2019-12-31
2017적정Term 74선진회계법인2019-12-31
2016적정Term 73신한회계법인2016-12-31
2015적정Term 72선진회계법인2016-12-31
2014적정Term 71선진회계법인2016-12-31

The auditor's name and the opinion are transcribed verbatim from the filed audit report, and the wording follows the filer. A fiscal year shown twice means the filing carried two entries that the source does not distinguish.

Korean audit opinions come in four kinds, where an unqualified opinion (적정) finds the statements fairly presented, a qualified opinion (한정) does so except for a stated matter, an adverse opinion (부적정) finds them not fairly presented, and a disclaimer of opinion (의견거절) means the auditor could not obtain enough evidence to form a view.

Valuation

Valuation multiplesx

PER and PBR divide each period's closing price by the per-share figure filed for that same period, and a loss period is left blank. The quarterly view is a multiple of quarterly EPS.

Dividend historyKRW

The dividend-per-share bars are restated onto the current share basis for splits and par-value changes. The payout ratio and the dividend yield divide figures filed for the same period and are left unadjusted.

Payout ratio and dividend yield%

PER bandKRW

The price is the adjusted close and each band line multiplies the EPS of the latest completed fiscal year by a fixed multiple. The previous year's EPS stays in force until the next fiscal year ends, and the multiples divide the range between the lowest and highest annual PER on record into equal steps.

Valuation models

Five models priced under one set of assumptions, set beside the current price, with how each has moved by fiscal year.

Assumptions

Risk-free rate10-year treasury yield · 2026-10-084.40%
BetaDaily 5Y1.17
%
%
Cost of equity10.25%
Weighted average cost of capital—
Initial growth1.5%
Effective tax rate3.9%
Base fiscal year2025
Current priceKRW243,500

The risk premium and the terminal growth rate are adjustable assumptions, and the rest follow from the data and the formulas.

ModelModel priceKRWVersus current price
Gordon growth model618-99.7%
Dividend discount model DDM611-99.7%
Discounted cash flow FCFFBase-year cash flow not positive
Discounted cash flow FCFEBase-year cash flow not positive
Residual income model RIM64-100.0%
The table prices the newest fiscal year's accounts at today's treasury yield and the current price.

Dividend and residual income familyKRW

Discounted cash flow familyKRW

Each fiscal year's figures use that year's accounts and the treasury yield at its period end, with beta held at its current value, and splits or par changes are restated to the current share basis.

How the figures are calculated

Each model's formula is shown in symbols and then with this issue's own numbers substituted, step by step. Changing a value in the assumptions panel changes the numbers here too. Firm-level amounts are in hundred million won and per-share values in won.

Cost of equity

r=rf+β×ERPr = r_f + \beta \times \mathit{ERP}

r = 4.40% + 1.17 × 5.00% = 10.25%

Initial growth

g1=max⁡{ROE×(1−payout), 0},gt=g1+(gT−g1) t−1N−1g_1 = \max\{\mathit{ROE} \times (1 - \text{payout}),\,0\},\qquad g_t = g_1 + (g_T - g_1)\,\frac{t-1}{N-1}

g_1 = max(1.91% × (1 − 22.12%), 0) = 1.48%

Growth starts at this value in the first year and falls by equal steps each year to reach the terminal rate in the fifth

Gordon growth model

P0=D0 (1+gT)r−gTP_0 = \frac{D_0\,(1 + g_T)}{r - g_T}

P_0 = 50 × (1 + 2.00%) / (10.25% − 2.00%) = 51 / 0.0825 = 618 KRW

Dividend discount model DDM

P0=∑t=1NDt(1+r)t+DN(1+gT)(r−gT) (1+r)N,Dt=Dt−1(1+gt)P_0 = \sum_{t=1}^{N} \frac{D_t}{(1+r)^t} + \frac{D_N (1+g_T)}{(r - g_T)\,(1+r)^N},\qquad D_t = D_{t-1}(1+g_t)

D_0 = 50, g_1 = 1.48%, g_T = 2.00%, r = 10.25%

YearGrowthDividend KRWDiscount factorPresent value KRW
11.48%510.907046
21.61%520.822742
31.74%520.746239
41.87%530.676836
52.00%550.613833
Terminal value2.00%6740.6138414
Total611

P_0 = 611 KRW

Residual income model RIM

P0=B0+∑t=1NRIt(1+r)t+RIN(1+gT)(r−gT) (1+r)N,RIt=(ROE−r) Bt−1P_0 = B_0 + \sum_{t=1}^{N} \frac{\mathit{RI}_t}{(1+r)^t} + \frac{\mathit{RI}_N (1+g_T)}{(r - g_T)\,(1+r)^N},\qquad \mathit{RI}_t = (\mathit{ROE} - r)\,B_{t-1}

B_0 = 11,767 KRW, ROE = 1.91%, payout ratio = 22.12%, r = 10.25%, g_T = 2.00%

YearOpening book valueEarningsEquity chargeResidual incomeDiscount factorPresent value
111,7672241,206-9820.9070-891
211,9412281,224-9970.8227-820
312,1192311,242-1,0110.7462-755
412,2992341,261-1,0260.6768-695
512,4812381,280-1,0420.6138-639
Terminal value-12,8750.6138-7,903

P_0 = 11,767 + -3,800 + -7,903 = 64 KRW

The cost of equity is the risk-free rate plus beta times the equity risk premium. Initial growth is the newest fiscal year's return on equity times its retention ratio, floored at zero, and falls by equal steps from that value in the first year to the terminal rate in the fifth. Only the Gordon model grows at the terminal rate from the start. Discounted cash flow starts from operating cash flow less capital expenditure, where FCFF adds after-tax interest paid and discounts at the weighted average cost of capital, and FCFE adds net borrowing and discounts at the cost of equity. The residual income model adds to book value per share the present value of earnings above the equity charge.